BRIEF-Insys Therapeutics announces FDA final product label for Syndros
May 24, 2017 at 07:06 AM EDT
* Insys Therapeutics Inc says syndros is approved for use in treating anorexia associated with weight loss in patients with acquired immune deficiency syndrome
